Adagene Stock Investor Sentiment

ADAG Stock  USD 1.77  0.20  10.15%   
Roughly 54% of Adagene's investor base is interested to short. The analysis of the overall investor sentiment regarding Adagene suggests that many traders are impartial. The current market sentiment, together with Adagene's historical and current headlines, can help investors time the market. In addition, many technical investors use Adagene stock news signals to limit their universe of possible portfolio assets.
  

Adagene Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Adagene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at globenewswire.com         
Adagene to Present at 11th Annual Immuno-Oncology 360 Summit
Macroaxis News: globenewswire.com
2 days ago at gurufocus.com         
Adagene to Present at 11th Annual Immuno-Oncology 360 Summit
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
Adagene to Present at 11th Annual Immuno-Oncology 360 Summit
Yahoo News
over a week ago at globenewswire.com         
Adagene to Present at Leerinks Global Healthcare Conference 2025
Macroaxis News: globenewswire.com
over a week ago at finance.yahoo.com         
Adagene to Present at Leerinks Global Healthcare Conference 2025
Yahoo News
over a week ago at gurufocus.com         
Adagene to Present at Leerinks Global Healthcare Conference 2025
Gurufocus Stories at Macroaxis
over two weeks ago at globenewswire.com         
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug in Colorectal Canc...
Macroaxis News: globenewswire.com
over two weeks ago at finance.yahoo.com         
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug in Colorectal Canc...
Yahoo News
over two weeks ago at gurufocus.com         
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug in ...
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
Adagene Inc. Short Interest Update - MarketBeat
Google News at Macroaxis
over a month ago at gurufocus.com         
FIL Ltds Strategic Acquisition of Adagene Inc Shares An In-Depth Analysis
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
Morgan Stanley Downgrades Adagene to Equal Weight - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Morgan Stanley Downgrades Adagene to Equal Weight From Overweight -January 31, 2025 at 0757 am EST -...
Google News at Macroaxis
over a month ago at news.google.com         
FY2024 Earnings Forecast for Adagene Issued By HC Wainwright - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
FY2029 Earnings Estimate for Adagene Issued By HC Wainwright - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Adagene that are available to investors today. That information is available publicly through Adagene media outlets and privately through word of mouth or via Adagene internal channels. However, regardless of the origin, that massive amount of Adagene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Adagene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adagene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adagene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adagene alpha.

Adagene Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Is Bioventus Outperforming Other Medical Stocks This Year
12/23/2024
2
Is Adagene Stock Outpacing Its Medical Peers This Year
01/08/2025
3
Adagene to Announce Updated Data from Phase 1b2 Study of Muzast
01/21/2025
4
Adagene Announces Updated Data from Phase 1b2 Study of Muzastot
01/27/2025
5
FY2024 Earnings Forecast for Adagene Issued By HC Wainwright - MarketBeat
01/29/2025
6
FIL Ltds Strategic Acquisition of Adagene Inc Shares An In-Depth Analysis
02/12/2025
7
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug in Colorectal Cancer
02/27/2025
8
Adagene to Present at Leerinks Global Healthcare Conference 2025
03/06/2025
9
Adagene to Present at 11th Annual Immuno-Oncology 360 Summit
03/13/2025

Complementary Tools for Adagene Stock analysis

When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets